Follow
Stephen Schmechel
Stephen Schmechel
Boise Pathology Group; St. Luke's Health System
Verified email at slhs.org - Homepage
Title
Cited by
Year
Automated detection and annotation of prostate cancer on histopathology slides
EY Leng, GJ Metzger, JS Koopmeiners, J Henriksen, SC Schmechel
US Patent 11,631,171, 2023
2023
Safety, feasibility, and merits of longitudinal molecular testing of multiple metastatic sites to inform mTNBC patient treatment in the intensive trial of omics in cancer
KA Burton, E Mahen, EQ Konnick, S Blau, MO Dorschner, AB Ramirez, ...
JCO Precision Oncology 6, e2100280, 2022
12022
Differential outcomes of patients with thyroid FNA diagnoses of AUS/FLUS with and without nuclear atypia: The potential need for separation in the Bethesda System
G Deftereos, SC Schmechel, EE Waner, M Itani, MK Dighe, TS Tylee
Diagnostic cytopathology 48 (7), 610-617, 2020
62020
Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E-and IHC-stained histopathological specimens
E Leng, JC Henriksen, AE Rizzardi, J Jin, JW Nam, BM Brassuer, ...
Scientific reports 9 (1), 6992, 2019
102019
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
PJ Beckmann, JD Larson, AT Larsson, JP Ostergaard, S Wagner, ...
Cancer research 79 (5), 905-917, 2019
412019
Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models
GJ Metzger, SC Schmechel, C Kalavagunta, JS Koopmeiners, CA Warlick
US Patent 9,858,665, 2018
92018
Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant …
DM Seelig, D Ito, CL Forster, UA Yoon, M Breen, LJ Burns, V Bachanova, ...
Leukemia & lymphoma 58 (7), 1702-1710, 2017
152017
Safe and effective sarcoma therapy through bispecific targeting of EGFR and uPAR
A Borgatti, JS Koopmeiners, AL Sarver, AL Winter, K Stuebner, ...
Molecular cancer therapeutics 16 (5), 956-965, 2017
442017
Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer
AE Rizzardi, X Zhang, RI Vogel, S Kolb, MS Geybels, YK Leung, ...
Diagnostic pathology 11, 1-11, 2016
412016
Cis-Compound Mutations are Prevalent in Triple Negative Breast Cancer and Can Drive Tumor Progression
N Hiranuma, J Liu, C Song, J Goldsmith, MO Dorschner, CC Pritchard, ...
bioRxiv, 085316, 2016
12016
Development of quantitative multiparametric MRI models for prostate cancer detection using registered correlative histopathology
GJ Metzger, C Kalavagunta, B Spilseth, PJ Bolan, X Li, D Hutter, JW Nam, ...
Radiology 279 (3), 805, 2016
22016
Detection of prostate cancer: quantitative multiparametric MR imaging models developed using registered correlative histopathology
GJ Metzger, C Kalavagunta, B Spilseth, PJ Bolan, X Li, D Hutter, JW Nam, ...
Radiology 279 (3), 805-816, 2016
792016
Integrating whole exome sequencing data with RNAseq and quantitative proteomics to better inform clinical treatment decisions in patients with metastatic triple negative breast …
P Soon-Shiong, S Rabizadeh, S Benz, F Cecchi, J Golovato, ...
Cancer Res 76 (4 Suppl), P6-05, 2016
42016
Differential Outcomes of Patients with FNA Diagnoses of AUS Versus FLUS: The Potential Need for Separation in the Bethesda System
G Deftereos, TS Tylee, EE Waner, M Itani, MK Dighe, SC Schmechel
LABORATORY INVESTIGATION 96, 96A-96A, 2016
2016
A distributed network for intensive longitudinal monitoring in metastatic triple-negative breast cancer
CA Blau, AB Ramirez, S Blau, CC Pritchard, MO Dorschner, ...
Journal of the National Comprehensive Cancer Network 14 (1), 8-17, 2016
262016
CYP3A4 epoxygenase activity mediates ER+ mammary tumor growth and angiogenesis, in part, through EET biosynthesis and is inhibited by biguanides
Z Guo, IF Sevrioukova, E Hanse, I Denisov, X Zhang, TL Chiu, D Swedien, ...
Cancer Research 75 (15_Supplement), 3568-3568, 2015
2015
Registration of in vivo prostate MRI and pseudo‐whole mount histology using Local Affine Transformations guided by Internal Structures (LATIS)
C Kalavagunta, X Zhou, SC Schmechel, GJ Metzger
Journal of Magnetic Resonance Imaging 41 (4), 1104-1114, 2015
542015
Quantification of Tumor Heterogeneity in Whole Slide Images of Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4
N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ...
MODERN PATHOLOGY 28, 254A-254A, 2015
2015
Prostate Cancer Using a Three Biomarker Panel of RHAMM, SIAH2, and SMAD4
N Reder, J Henriksen, A Rizzardi, J Koopmeiners, G Metzger, ...
LABORATORY INVESTIGATION 95, 254A-254A, 2015
2015
Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath Tumorigenesis
EP Rahrmann, BS Moriarity, GM Otto, AL Watson, K Choi, MH Collins, ...
The American Journal of Pathology, 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20